Literature DB >> 8359180

Chlorpromazine in human scalp hair as an index of dosage history: comparison with simultaneously measured haloperidol.

H Sato1, T Uematsu, K Yamada, M Nakashima.   

Abstract

The concentration of chlorpromazine (CPZ) in hair was measured to demonstrate its value as an index of individual dosage history and compliance. An animal study using pigmented rats was conducted to confirm the dose-dependent accumulation of CPZ in hair. The concentration of CPZ in hair, newly regrown on a denuded area of the back after the administration of CPZ for 3 weeks, was 4.6, 8.5 and 16.6 ng.mg-1 hair after daily doses of 1.25, 2.5 and 5 mg.kg-1.day-1, respectively, significantly correlated with the daily dose. The concentration of CPZ in black hairs collected from 23 Japanese patients, who had been taking CPZ in fixed daily doses (30-300 mg/day), ranged from 1.6 to 27.5 ng.mg-1, and was significantly correlated both with the daily dose and with the trough plasma concentration at steady state. Several strands of hair collected from each of 5 patients, whose doses of CPZ had been changed within several months before sampling, were cut into 1-cm pieces successively from the scalp end and the concentration of CPZ in each piece was measured. With the assumption of a hair growth rate of 1 cm per month, the individual history of CPZ doses in all patients could be deduced from the distribution of CPZ along the hair shaft. In 5 patients with grizzled hair the concentration of CPZ in white hairs was much lower (< 10%) than in black hairs, suggesting that the strong affinity of CPZ for hair melanin may explain the accumulation of CPZ in black hair.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8359180     DOI: 10.1007/bf00315540

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  17 in total

1.  Human scalp hair as evidence of individual dosage history of haloperidol: longer-term follow-up study.

Authors:  T Uematsu; R Sato
Journal:  Ther Drug Monit       Date:  1990-11       Impact factor: 3.681

2.  Studies on the mechanism of drug-binding to melanin.

Authors:  B Larsson; H Tjälve
Journal:  Biochem Pharmacol       Date:  1979-04-01       Impact factor: 5.858

3.  Interactions between human melanoprotein and chlorpromazine derivatives. I. Isolation and purification of human melanoprotein from hair and melanoma tissue.

Authors:  A G Bolt
Journal:  Life Sci       Date:  1967-06-15       Impact factor: 5.037

Review 4.  Plasma level monitoring of antipsychotic drugs. Clinical utility.

Authors:  S G Dahl
Journal:  Clin Pharmacokinet       Date:  1986 Jan-Feb       Impact factor: 6.447

5.  Detection of phencyclidine in hair.

Authors:  A M Baumgartner; P F Jones; C T Black
Journal:  J Forensic Sci       Date:  1981-07       Impact factor: 1.832

6.  The measurement of ofloxacin in hair as an index of exposure.

Authors:  T Uematsu; N Miyazawa; M Nakashima
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

7.  Total mercury concentrations in human hair from 13 countries in relation to fish consumption and location.

Authors:  D Airey
Journal:  Sci Total Environ       Date:  1983-11       Impact factor: 7.963

8.  Chlorpromazine plasma level monitoring of schizophrenic patients.

Authors:  E E Jones
Journal:  J Clin Pharm Ther       Date:  1988-12       Impact factor: 2.512

9.  The measurement of haloperidol and reduced haloperidol in hair as an index of dosage history.

Authors:  H Matsuno; T Uematsu; M Nakashima
Journal:  Br J Clin Pharmacol       Date:  1990-02       Impact factor: 4.335

10.  Chlorpromazine levels and the outcome of treatment in schizophrenic patients.

Authors:  P R May; T Van Putten; D J Jenden; C Yale; W J Dixon
Journal:  Arch Gen Psychiatry       Date:  1981-02
View more
  5 in total

Review 1.  Therapeutic drug monitoring in hair samples. Principles and practice.

Authors:  T Uematsu
Journal:  Clin Pharmacokinet       Date:  1993-08       Impact factor: 6.447

2.  Dose-hair concentration relationship and pigmentation effects in patients on low-dose clozapine.

Authors:  R Kronstrand; M Roman; M Hedman; J Ahlner; N Dizdar
Journal:  Forensic Sci Med Pathol       Date:  2007-05-09       Impact factor: 2.007

3.  Using ofloxacin as a time marker in hair analysis for monitoring the dosage history of haloperidol.

Authors:  M Nakano; T Uematsu; H Sato; K Kosuge; M Nishimoto; M Nakashima
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

4.  The axial distribution of nicotine content along hair shaft as an indicator of changes in smoking behaviour: evaluation in a smoking-cessation programme with or without the aid of nicotine chewing gum.

Authors:  T Uematsu; A Mizuno; S Nagashima; A Oshima; M Nakamura
Journal:  Br J Clin Pharmacol       Date:  1995-06       Impact factor: 4.335

5.  Analysis of a new fluoroquinolone derivative (Q-35) in human scalp hair as an index of drug exposure and as a time marker in hair.

Authors:  T Uematsu; Y Ohsawa; A Mizuno; M Nakashima
Journal:  Int J Legal Med       Date:  1994       Impact factor: 2.686

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.